Biotech Values

[nuere]

I re-entered into OXGN today because I think they can surprise at ASCO and I guess it couldn't harm that they also have Tamar on their board..

If what IDIX wanted was a director with experience in biotech partnerships and M&A transactions, a better pick than Ms. Howson would be hard to find. She has held senior business-development positions at BMY, LEXG, and SmithKline Beecham (now part of GSK). Howson also has an engineering degree from Technion in Israel, one of the world’s premiere academic institutions.